Background: Recently, advances have emerged in medicine and pharmacotherapeutics, providing novel treatments for tuberculosis (TB). It is noteworthy that long-term drug consumption for TB treatment often leads to hepatotoxicity, which can have serious or even fatal side effects. Thus, many studies have focused on the assessment of the hepatoprotective effects of betaine, a glycine derivative. This study aimed at evaluating the effects of betaine to explore the underlying biochemical mechanisms of hepatotoxicity in rats, using combined isoniazid (INH) and rifampicin (RMP).
No takes yet. Share an insight, caveat, or question.
John et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: